HRT Financial’s AgomAb Therapeutics NV AGMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$353K Buy
31,881
+14,806
+87% +$192K ﹤0.01% 3237
2026
Q2
$221K Sell
17,075
-6,651
-28% -$74.9K ﹤0.01% 3344
2026
Q1
$248K Buy
+23,726
New +$336K ﹤0.01% 3048

Other funds holding AGMB

HRT Financial's AGMB Position: Q3 2026 in Review

HRT Financial increased its AgomAb Therapeutics NV (AGMB) stake by 87% in Q3 2026, buying an estimated $192K and bringing the position to 31,881 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3237.

HRT Financial first reported a position in AGMB in Q1 2026 and has held it in 3 quarters since. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • HRT Financial held 31,881 shares of AgomAb Therapeutics NV worth $353K as of Q3 2026.
  • HRT Financial bought 14,806 AgomAb Therapeutics NV shares in Q3 2026, an estimated $192K.
  • AgomAb Therapeutics NV made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #3237 holding.
  • HRT Financial first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 3 quarters since.
  • 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.